Description
Cell line name NCC-CDS2-C1
Accession CVCL_YL70
Resource Identification Initiative To cite this cell line use: NCC-CDS2-C1 (RRID:CVCL_YL70)
Comments Part of: NCC sarcoma cell line panel.
Population: Japanese.
Doubling time: ~28 hours (PubMed=31898195).
Sequence variations
Gene fusion; HGNC; 14214; CIC + HGNC; 50800; DUX4; Name(s)=CIC-DUX4 (PubMed=31898195).
Disease CIC-DUX4 sarcoma (NCIt: C165663)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Sex of cell Female
Age at sampling 50Y
Category Cancer cell line
STR profile
Source(s): PubMed=31898195
Markers:
Amelogenin | X |
CSF1PO | 10 |
D5S818 | 8,11 |
D7S820 | 8,9 |
D13S317 | 8,11 |
D16S539 | 9,11 |
D21S11 | 29,30 |
TH01 | 7,9 |
TPOX | 8,9 |
vWA | 14,17 |
Publications
PubMed=31898195; DOI=10.1007/s13577-019-00312-x
Yoshimatsu Y., Noguchi R., Tsuchiya R., Kito F., Sei A., Sugaya J., Nakagawa M., Yoshida A., Iwata S., Kawai A., Kondo T.
Establishment and characterization of NCC-CDS2-C1: a novel patient-derived cell line of CIC-DUX4 sarcoma.
Hum. Cell 33:427-436(2020)
Cross-references
Encyclopedic resources Wikidata; Q95992508
Reviews
There are no reviews yet.